Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-12-04 18:00 |
Valneva - Déclaration d’actions et de droits de vote – NOVEMBRE 2020
|
English | 204.9 KB | ||
| 2020-12-02 17:45 |
Valneva Announces Acceleration of Pediatric Development for Lyme Disease Vaccin…
|
English | 660.4 KB | ||
| 2020-12-02 17:45 |
Valneva annonce l’accélération du développement pédiatrique de son candidat vac…
|
French | 870.7 KB | ||
| 2020-12-01 15:45 |
Valneva annonce la mise à disposition des documents préparatoires à son Assembl…
|
French | 382.6 KB | ||
| 2020-12-01 15:45 |
Valneva Announces the Availability of Documentation for its Extraordinary Gener…
|
English | 312.6 KB | ||
| 2020-11-10 17:45 |
Valneva annonce la tenue d’une assemblée générale extraordinaire dans la perspe…
|
French | 390.3 KB | ||
| 2020-11-10 17:45 |
Valneva Announces Plans for Extraordinary General Meeting to Prepare for Potent…
|
English | 306.5 KB | ||
| 2020-11-04 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote – OCTOBRE 2020
|
French | 205.0 KB | ||
| 2020-11-04 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote – OCTOBRE 2020
|
French | 205.0 KB | ||
| 2020-11-03 07:00 |
Valneva publie ses résultats pour les neuf premiers mois de l’exercice 2020 mar…
|
French | 747.1 KB | ||
| 2020-11-03 07:00 |
Valneva Reports Nine Month Results Marked by Further Major Corporate Achievemen…
|
English | 725.0 KB | ||
| 2020-10-20 18:45 |
Valneva annonce des résultats initiaux positifs pour la seconde Phase 2 du cand…
|
French | 862.3 KB | ||
| 2020-10-20 18:45 |
Valneva Announces Positive Initial Results for Second Phase 2 Study of Lyme Dis…
|
English | 681.3 KB | ||
| 2020-10-16 07:00 |
Valneva obtient le statut PRIME de l’Agence européenne des médicaments pour son…
|
French | 504.5 KB | ||
| 2020-09-18 07:00 |
Valneva Announces Retirement of Chief Financial Officer David Lawrence
|
English | 305.3 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
